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Transcriptome Analysis of Psoriasis in a Large
Case–Control Sample: RNA-Seq Provides Insights
into Disease Mechanisms
Bingshan Li1,2,6, Lam C. Tsoi2,6, William R. Swindell3, Johann E. Gudjonsson3, Trilokraj Tejasvi3,4,
Andrew Johnston3, Jun Ding2,5, Philip E. Stuart3, Xianying Xing3, James J. Kochkodan3, John J. Voorhees3,
Hyun M. Kang2, Rajan P. Nair3, Goncalo R. Abecasis2 and James T. Elder3,4
To increase our understanding of psoriasis, we used high-throughput complementary DNA sequencing
(RNA-seq) to assay the transcriptomes of lesional psoriatic and normal skin. We sequenced polyadenylated
RNA-derived complementary DNAs from 92 psoriatic and 82 normal punch biopsies, generating an average of
B38 million single-end 80-bp reads per sample. Comparison of 42 samples examined by both RNA-seq and
microarray revealed marked differences in sensitivity, with transcripts identified only by RNA-seq having much
lower expression than those also identified by microarray. RNA-seq identified many more differentially expressed
transcripts enriched in immune system processes. Weighted gene coexpression network analysis (WGCNA)
revealed multiple modules of coordinately expressed epidermal differentiation genes, overlapping significantly
with genes regulated by the long noncoding RNA TINCR, its target gene, staufen-1 (STAU1), the p63 target gene
ZNF750, and its target KLF4. Other coordinately expressed modules were enriched for lymphoid and/or myeloid
signature transcripts and genes induced by IL-17 in keratinocytes. Dermally expressed genes were significantly
downregulated in psoriatic biopsies, most likely because of expansion of the epidermal compartment. These
results show the power of WGCNA to elucidate gene regulatory circuits in psoriasis, and emphasize the
influence of tissue architecture in both differential expression and coexpression analysis.
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INTRODUCTION
Psoriasis is a chronic inflammatory disease of the skin and
joints, affecting B0.2–2% of the world’s population (Nestle
et al., 2009; Gudjonsson and Elder, 2012). Microarray-based
studies of the psoriatic transcriptome have revealed a large
number of differentially expressed genes (DEGs) in lesional
skin (Bowcock et al., 2001; Zhou et al., 2003; Reischl et al.,
2007; Yao et al., 2008; Zaba et al., 2009; Gudjonsson et al.,
2010; Suarez-Farinas et al., 2010), both in case–control
comparisons and in lesional and normal skin from the same
individual. Moreover, one study of nonlesional psoriatic
versus normal skin identified over 200 DEGs (Gudjonsson
et al., 2009). Recently, high-throughput complementary DNA
sequencing (RNA-seq) has emerged as a powerful alternative
to microarrays (Wang et al., 2009; Metzker, 2010; Garber
et al., 2011; Liu et al., 2011; Ozsolak and Milos, 2011;
Roy et al., 2011) that provides increased accuracy and
precision (Roy et al., 2011), identifies unmapped transcripts
and alternative splicing, and markedly can increase the
dynamic range of detection (Wang et al., 2009; Liu et al.,
2011). To date, there has been only one study using RNA-seq
to analyze the coding psoriatic transcriptome (Jabbari et al.,
2012), examining three pairs of lesional and normal skin
samples from psoriatic individuals, and one other study
limited to the microRNA genome (Joyce et al., 2011).
In this paper, we report findings from a large-scale RNA-seq
analysis of skin biopsies from 174 individuals. A subset of
these samples has been studied previously using microarrays
(Gudjonsson et al., 2009, 2010), allowing for a robust
comparison of the two technologies. In addition, the large
sample size we consider permits new modes of data analysis,
such as gene coexpression network analysis (Barabasi and
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Oltvai, 2004; Zhang and Horvath, 2005; Langfelder and
Horvath, 2007, 2008; Yip and Horvath, 2007; Horvath and
Dong, 2008; De Las Rivas and Fontanillo, 2010). Our results
show the value of RNA-seq in capturing the full dynamic
range of the psoriatic transcriptome, identify key transcription
factors involved in psoriasis, and reveal gene coexpression
networks illuminating the processes of keratinocyte differen-
tiation, lipid biosynthesis, and the inflammatory interplay
between myeloid cells, T cells, and keratinocytes. We also
show that expansion of the epidermal compartment provides
an architectural explanation for the apparent downregulation
of dermally derived transcripts in psoriatic lesions.
RESULTS
Comparison of RNA-seq and microarray results
Using the Illumina GAII platform, we sequenced libraries
constructed from complementary DNA prepared from poly-
adenylated RNA extracted from skin biopsies donated by 92
psoriatic patients and 82 normal individuals. From reads
averaging 80 bp in length, we generated on average 38±10
(mean±SD) million reads per sample, yielding approximately
3 gigabases of complementary DNA sequence per sample. We
aligned the reads to the NCBI build 37 reference genome
using TopHat (Garber et al., 2011), yielding an average
mapping rate of 80±6% (mean±SD). After performing
quality control (see Materials and Methods), gene expression
levels, represented as reads per kilobase per million mapped
reads (RPKM) (Mortazavi et al., 2008), were obtained for
21,099 genes annotated in the RefSeq database (Pruitt et al.,
2007). We identified 3,577 DEGs between lesional and
normal skin (|log2FC|X1 and Po1 10 6, corresponding
to family-wise error rate o0.025), of which 1,049 were
upregulated and 2,528 were downregulated in psoriasis (the
full list of DEGs is provided in Supplementary Table S1
online). We then performed analysis to investigate the poten-
tial splicing events based on differential usage of exons
(Anders et al., 2012). We identified 343 exons (from 292
genes) with differential usage between the psoriatic and
normal skin conditions. Notably, only 95 of the genes were
differentially expressed based on the gene-level analysis
(Supplementary Table S1 online).
In previous studies (Gudjonsson et al., 2009, 2010), we
measured gene expression using Affymetrix HU133 Plus 2.0
microarrays on 122 skin samples (58 lesional and 64 normal).
Among these, 42 samples overlap with the present experiment
(20 lesional and 22 normal). We first examined the expression
levels for the 42 samples assayed on both platforms. In
general, RNA-seq and microarray measurements were
consistent for intermediate- and high-abundance transcripts,
whereas discrepancies become noticeable for low-abundance
transcripts in both cases and controls (Supplementary Figure
S1 online). We then compared each gene’s fold-change (FC)
estimates derived using microarrays with those obtained by
RNA-seq (Supplementary Figure S2a online). For medium- and
high-abundance transcripts, FC estimates were relatively con-
sistent between the two platforms (Supplementary Figure S2c
and d online). In contrast, for low-abundance transcripts
(Supplementary Figure S2b online), RNA-seq had a wider
range of FC estimates, which is in agreement with other
studies (Marioni et al., 2008; Bradford et al., 2010).
We next compared our set of DEGs with our full microarray
data set (Gudjonsson et al., 2010). Over 80% (i.e., 794/987) of
the genes identified in the microarray analysis were also
flagged by RNA-seq, but only 22% (794/3,577) of the genes
identified by RNA-seq were flagged by microarray analysis
(Supplementary Figure S3 online). Again, DEGs detected only
by RNA-seq tended to be low-abundance transcripts
(Supplementary Figure S4 online, panels a and b), whereas
those identified by both platforms (Supplementary Figure S4
online, panels c and d) or only using microarrays (Supple-
mentary Figure S4 online, panels e and f) tended to be
intermediate- and high-abundance transcripts. We observed
very similar patterns when we restricted the analysis to only
those genes and samples that overlapped between the RNA-
seq and microarray experiments (Supplementary Figure S5
online). We did not observe any difference in the distributions
of gene length, number of exons, and number of transcripts in
genes identified as DEGs only by RNA-seq, only by micro-
arrays, or by both platforms (Supplementary Figure S6 online).
Using the same statistical criteria that we have used in this
analysis, we reprocessed available microarray data in order to
compare the number and percentage of the overlap of DEGs
between our data sets and other independent data sets (Zaba
et al., 2009; Suarez-Farinas et al., 2012). These results are
presented in Supplementary Table S2 online.
Analysis of DEGs
We performed pathway analyses to identify biological func-
tions/pathways enriched among the DEGs. The most signifi-
cantly enriched functions among the upregulated genes
included ‘‘inflammatory responses’’ (P¼61031), ‘‘cyto-
kine-receptor interactions’’ (P¼6 1027), ‘‘cell division’’
(P¼ 21015), and ‘‘keratinization’’ (P¼4 10 14). Using
the cytokine–cytokine receptor interaction pathway as an
example, 14 of the 17 genes having the highest differences
in expression between psoriatic and normal skin were not
identified as DEGs in a recent microarray-based study of
psoriatic skin (Gudjonsson et al., 2010; Supplementary Table
S3 online). We performed quantitative real-time reverse-
transcriptase–PCR experiments on 8 out of the 17 genes listed
in Supplementary Table S3 online, and validated that their
expression levels are all significantly differentially expressed
(Supplementary Table S3 online). The most significantly
enriched functions among the downregulated genes included
‘‘calcium ion binding’’ (P¼41021), ‘‘homophilic cell
adhesion’’ (P¼ 5 10 20), and ‘‘muscle contraction’’ (P¼ 1
 1017). Subsequent analysis revealed that many of these
genes were of dermal origin and systematically underex-
pressed owing to expansion of the epidermal compartment
in psoriatic lesions (see below). However, the 16 DEGs
showing enrichment for ‘‘keratinization’’ that were detected
only by RNA-seq comprised a mixture of upregulated and
downregulated genes, and only 4 of which were represented
on the HU133 Plus 2.0 microarray platform. Supplementary
Table S4 online shows the full list of significantly enriched
functions and the genes contributing to each.
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DEGs attributable to Th17 function (Ouyang et al., 2008)
were prominent in our sample, including IL-12B, IL-17A,
IL-17F, IL-21, IL-22, IL-26, IL-21R, and IL-23R. With the
exception of IL-26 and IL-21R, increased expression of these
genes has previously been described in lesional psoriasis
(Teunissen et al., 1998; Lee et al., 2004; Caruso et al.,
2009). Although their expression in psoriatic skin was quite
low, their expression was often undetectable in normal skin
(Supplementary Table S2 online). Other notable immune-
related genes that are significantly upregulated included
IFN-g (IFNG, 41000-fold), IFN-e (IFNE, 41000-fold), nitric
oxide synthase (NOS2, 50-fold), IL-6 (IL-6, 4.3-fold), and IL-24
(IL-24, 4-fold); IL-34 is significantly downregulated (IL-34,
7-fold suppressed).
To examine transcriptional mechanisms underlying the
differential expression of genes identified by RNA-seq, we
performed a transcription factor analysis using the Ingenuity
Pathway Analysis software. The results revealed significant
enrichment for the targets of 61 transcription factors
(Supplementary Table S5 online). Of these, 15 were predicted
to be in an activated state in psoriatic skin, 12 were predicted
to be in an inhibited state, and the remaining 34 yielded no
prediction regarding activation. Among those predicted to be
activated, the most significant (Po1 10 10) enrichment
involved targets of the proinflammatory transcription factors
signal transducer and activator of transcription 3 (STAT3),
NF-kB, CCAAT/enhancer-binding protein beta, and STAT1,
whereas peroxisome proliferator–activated receptor-g (PPAR-g)
and forkhead box protein A2 were predicted to be inhibited.
PPAR-g is a major regulator of genes involved in lipid
metabolism, water transport, and cornified envelope formation
during keratinocyte differentiation (Jiang et al., 2011). Similar
to PPAR-g, forkhead box protein A2 regulates networks of
genes controlling complex metabolic functions (Soccio et al.,
2011) and shares many target genes with PPAR-g (Supple-
mentary Table S5 online).
Gene coexpression network analysis
We grouped transcripts with correlated expression levels into
gene coexpression modules using the weighted gene coex-
pression network analysis (WGCNA) approach, which max-
imizes the network’s scale-free properties (Zhang and
Horvath, 2005; Yip and Horvath, 2007; Horvath and Dong,
2008; Langfelder and Horvath, 2008). WGCNA identified
18 gene modules in normal skin and 27 in lesional psoriatic
skin. Figure 1 shows the average reads per kilobase per million
mapped reads, average Spearman correlations, and the pro-
portions of significantly upregulated and downregulated
genes in each of the modules. We then tested each module
for enrichment of specific biological functions or pathways
(Supplementary Table S6 online). Cluster annotations and
FC values for each gene are provided in Supplementary
Table S7 online.
Among the normal skin coexpression clusters, modules N10
and N15 had the highest proportion of upregulated genes
(each over 12%), and both were enriched for genes involved
in keratinization (P¼2 1010) or located in the epidermal
differentiation complex (P¼21010; Supplementary
Table S6 online). Among modules identified in psoriatic skin,
modules P20 and P26 had the highest proportion of upregu-
lated genes (each over 70%). Module P20 was enriched
for genes involved in inflammatory and immune responses
(P¼ 11019 and 6 10 18, respectively). Over 80% of
module P20 genes were upregulated in lesional skin, aver-
agingB9-fold difference in expression. Moreover, the average
Spearman correlations of expression levels for genes in
module P20 was much higher for lesional skin (r¼0.45) than
for normal skin (r¼0.07, Figure 1, Supplementary Table S6
online). Module P26 was significantly enriched for genes
involved in keratinization (P¼31020) and located in
the epidermal differentiation complex (P¼ 710 19).
Module P23 was not characterized by strong differential
expression, but, similar to modules N10, N15, and P26, it
was enriched for genes found in the epidermal differentiation
complex (P¼ 7 10 25) and/or involved in keratinization
(P¼ 91025). Consistent with the functional annotation
results, modules N10, N15, P23, and P26 are all significantly
enriched with the top signature genes of keratinocytes and
epidermis (Figure 2). As shown in Figure 3, these four modules
also have the highest proportions of overlap with transcripts
identified in previous studies as being expressed in the granular
layer of the epidermis (Toulza et al., 2007; Mattiuzzo et al.,
2011), and with genes regulated by the long noncoding RNA
TINCR and its target gene staufen-1 (STAU1), which have
been shown to regulate terminal differentiation of the
epidermis (Kretz et al., 2012), as well as the p63 target gene
ZNF750 and its target KLF4 (Sen et al., 2012; Figure 3).
Normal skin–derived modules N6 and N18 were signifi-
cantly enriched for dermal tissue signature transcripts
(Figure 2) related to extracellular space, as well as collagen
and glycosaminoglycan binding (Supplementary Table S6
online). Both of these modules had high proportions of
downregulated genes (Figure 1 and Supplementary Table S6
online). The apparent under-representation of dermis-derived
transcripts in psoriasis lesions was further assessed with the aid
of an existing data set derived from laser-capture microdissec-
tion of lesional versus nonlesional psoriatic skin (Mitsui et al.,
2012). Using this data set, we identified two sets of transcripts
that (a) were specific for either the epidermis or dermis (i.e.,
expression of genes are significantly elevated as compared
with other 23 cell types, see Supplementary Information
online for details), and (b) did not vary substantially in
their expression in lesional versus nonlesional psoriatic skin
based on the laser-capture microdissection experiment.
We then calculated the FC values (psoriasis vs. normal) for
each of these transcripts in our RNA-seq data set. As shown
in Supplementary Figure S7 online, the FC distribution
of epidermis-specific transcripts was centered on unity
(log2 FC¼ 0), as expected. However, the log2 FC value of
the dermis-specific transcripts was centered around –1.
This significant under-representation of dermal transcripts
(Wilcoxon rank-sum test Po2 10 16 when comparing
dermis-specific genes’ FCs with those from epidermis-specific
genes) can be explained by the marked expansion of the
epidermis that is characteristic of psoriatic lesions (Supple-
mentary Figure S7e online).
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The coexpressed gene modules with the most significantly
enriched functional annotations were modules N14 and P18
(Supplementary Table S6 online), both of which were enriched
with the function ‘‘keratin filament’’ (P¼310113 for N14;
P¼ 810 114 for P18). Indeed, 99 genes were common to
both of these modules, and the majority (76/99) of them are
hair keratins (Schweizer et al., 2007) or keratin-associated
proteins found mainly in hair follicles (Rogers et al., 2006).
Other hair follicle–specific genes mapped to these clusters
include S100A3 (Kizawa et al., 2011), DSG4 (Bazzi et al.,
2006), PADI3 (Dong et al., 2006), and trichohyalin (TCHH)
(Steinert et al., 2003). Moreover, both modules showed signifi-
cant (Po1104) overlap (32% for N14; 26% for P18) with
genes identified as downregulated in a paired microarray
comparison of bald versus normal human scalp (Garza et al.,
2012). Moreover, the 25 most highly downregulated genes in
that study included 18 of the same hair-specific keratins
observed in clusters N14 and P18, including 9 hair keratins,
6 keratin-associated proteins, S100A3, and TCHH, all of which
were downregulated by 4-fold or more in bald scalp.
The sebaceous gland and the arrector pili muscle are
anatomically joined to the hair follicle to form the pilosebac-
eous unit (Lever and Schaumburg-Lever, 1990; Fujiwara et al.,
2011). Consistent with this, module N16 was significantly
enriched for transcripts engaged in muscle contraction
(Supplementary Table S6 online), and module N17 was
significantly enriched for signature genes expressed in adipose
tissue (fat) but not in the dermis (Figure 2). Module N17 was
also significantly enriched for PPAR signaling transcripts (P¼
11011) (Supplementary Table S6 online), which would be
in keeping with the major role of PPAR-g in adipocyte
differentiation (Yessoufou and Wahli, 2010).
Three psoriatic modules (P13, P19, and P21) were signifi-
cantly enriched (Po11018) for immune-related functions,
had high proportions of upregulated genes, and exhibited
higher Spearman’s correlations in expression in lesional than
in normal skin (Supplementary Table S6 online). They also
contained the highest proportions of signature genes expressed
in lymphocytes and/or myeloid cells (Figure 2). As shown in
Figure 2, modules P13 and P19 were significantly enriched for
the signatures of several types of lymphocytes, as well as
dendritic cells, whereas module P21 manifested significant
overlap for myeloid but not lymphoid signature genes.
In an effort to determine to what extent specific cytokines
present in psoriatic lesions might influence the behavior of
lesional keratinocytes, we used the signature gene enrichment
approach to query coexpression modules expressed by kera-
tinocytes and/or epidermis for genes distinctively expressed by
cultured human keratinocytes treated with various cytokines
(Swindell et al., 2012, 2013). Interestingly, three (N15, P20,
and P26) out of the five modules manifesting a strong
keratinocyte gene expression signature (N10, N15, P20, P23,
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Figure 1. Averaged reads per kilobase per million mapped reads (RPKM) and proportion of DEGs for each module. Averaged RPKM among the genes (top panel),
proportions of upregulated (Up) and downregulated (Down) genes (middle panel), and the average Spearman’s correlation (bottom panel) for the coexpression
gene modules constructed from the normal (normal; left panel) and psoriatic (psoriatic; right panel) skin samples, respectively.
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and P26) were significantly enriched for signature genes
induced by IL-17 treatment (Table 1). Module P20 was also
enriched for signature genes upregulated by IL-1a. This
module was also significantly enriched for genes regulated
by the transcription factors STAT1, STAT3, and interferon
regulatory factor 3 (17 genes, P¼ 81011; 11 genes, P¼ 1.4
 109; and 14 genes, P¼2.7 10 9, respectively; Table 1
and data not shown).
IL37 (Nold et al., 2012) was the most downregulated gene
(FC¼0.10) in psoriatic module P23, which is strongly enriched
for genes expressed in the stratum granulosum and regulated
by TINCR and STAU1 (Figure 3). We performed quantitative
real-time reverse-transcriptase–PCR to measure IL37 mRNA
and immunostaining to localize IL-37 protein with respect to
the known keratinocyte differentiation marker loricrin. As
shown in Figure 4, IL37 mRNA was expressed at much lower
levels in lesional psoriatic skin compared with nonlesional
psoriatic skin and normal skin. IL-37 protein was readily
detectable and confined to the stratum granulosum of normal
and nonlesional psoriatic skin, where it colocalizes with
loricrin, whereas it was undetectable in lesional psoriatic skin.
DISCUSSION
Although this is not the first study to apply RNA-seq to the
study of psoriasis (Joyce et al., 2011; Jabbari et al., 2012),
the availability of a much larger sample provides a more
70
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comprehensive view of the processes influencing the psoriatic
transcriptome. Many of the differentially expressed genes that
we have detected by RNA-seq were not represented or
detected in previous microarray studies on psoriasis (Zhou
et al., 2003; Reischl et al., 2007; Yao et al., 2008; Zaba et al.,
2009; Gudjonsson et al., 2010; Suarez-Farinas et al., 2010,
2012), including a recent meta-analysis (Tian et al., 2012).
Comparison of similarly powered experiments using the same
statistical criteria revealed a substantial increase in the number
of DEGs detected by RNA-seq, with little effect on the
percentage of overlapping DEGs across studies (Supple-
mentary Table S2 online).
Inspired by earlier observations of coordinate gene expres-
sion in psoriasis (Elder et al., 1993; Kojima et al., 1994;
Hardas et al., 1996; Elder and Zhao, 2002), a major feature
of this study is the application of gene coexpression network
analysis to the RNA-seq data. Although similar analyses have
been fruitfully applied to the study of mouse skin carcino-
genesis (Quigley et al., 2009, 2011), to our knowledge this is
its first application to human skin.
Links to immunological networks
WGCNA identified three coexpression modules in psoriatic
skin that were significantly annotated for immune function
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and enriched for signature genes of myeloid cells (P21), or
both myeloid and T cells (P13 and P19; Figure 2). Consistent
with the known inflammatory/immune cell infiltration char-
acteristic of psoriasis lesions, each of these modules mani-
fested increased proportions of upregulated genes in psoriatic
skin (Figure 1, Supplementary Table S6 online).
Among modules significantly enriched for epidermis or
keratinocyte signature genes, modules N15, P20, and P26
were enriched for transcripts induced by IL-17 treatment of
keratinocytes in vitro (Table 1). Module P20 was also enriched
for genes regulated by activation of STAT1, STAT3, and
interferon regulatory factor 3 (Table 1). Together, these
findings suggest that psoriatic keratinocytes are responding
to a proinflammatory cytokine milieu in which IL-17 is
upregulated (Supplementary Table S1 online) and biologically
available (Di Meglio et al., 2011; Zhang et al., 2011; Shi et al.,
2012). This is of clinical relevance because biologicals
targeting IL-17, its receptor, and both subunits of IL-23 are
highly effective treatments for psoriasis (Lowes et al., 2013),
and IL-23 is a major signal supporting the expansion and
survival of T cells expressing IL-17 (Kryczek et al., 2008). As
module P26 is highly upregulated in psoriasis lesions
(Figure 1), keratinocyte differentiation–related (Figure 3) and
IL-17 responsive (Table 1), it seems likely that IL-17 may
promote innate host defense in the skin by signaling to the
outer layers comprising the epidermal barrier.
Links to epidermal lineage commitment
During development, lineage commitment occurs when multi-
potent stem cells are specified into three lineages—
the epidermis, the hair follicle, and the sebaceous gland
(Hsu et al., 2011). In this study, we have identified gene
coexpression modules that can be attributed to each lineage.
Modules N10, N15, P23, and P26 were highly expressed in
the epidermis (Figure 2). There was significant (Po1104)
overlap between genes mapping to these modules and genes
expressed in the stratum granulosum (Toulza et al., 2007;
Mattiuzzo et al., 2011; Figure 3). HOPX, which encodes
a homeodomain protein involved in regulating the balance
between epidermal proliferation and differentiation
(Obarzanek-Fojt et al., 2010), maps to modules N15 and
P23. HOPX is a target gene of the master epidermal
development transcription factor p63 (TP63), as are several
other downstream transcriptional regulators of epidermal
differentiation including GRHL3, KLF4, and ZNF750 (Sen
et al., 2012; Zarnegar et al., 2012), all of which mapped to
module N10. Notably, each of these genes maps to reported
psoriasis susceptibility loci (Yang et al., 2008; Birnbaum et al.,
Table 1. Results of enrichment tests for the modules containing the highest proportions of signature genes in
keratinocytes/epidermis
Enrichment testa
Gene signatures in cytokine-induced experiments
Condition
Module
label Hub genesb Functions
Transcription
factor Up Down
Normal 10 TMEM54; PKP3; LYPD3;
ST14; LAD1
EDC; keratinization;
3’ UTR-mediated
translational
regulation
15 C1orf68; LY6G6C; LCE1B;
NIPAL4; SLC46A2
Keratinization IL-17A (200 ng for 24 hours) IL-1a (10 ng for 24 hours);
IL-36g (5K ng for 24 hours);
IL-22 (20ng for 4 days)
Psoriatic 20 SERPINB4; SERPINB3;
SLC6A14; TGFA; HEPHL1
Inflammatory
response; immune
response;
extracellular space
STAT1; STAT3;
IRF3
IL-17A (200 ng for 24 hours);
IL-1a (10 ng for 24 hours);
IL-1a (25 ng for 48 hours)
23 LCE1C; LCE2B; LCE2C;
LCE2D; C1orf68
EDC; keratinization HR IL-36 g (5K ng for 24 hours);
IL-36RA (5K ng for 24 hours);
IL-36b (5K ng for 24 hours)
26 CNFN; TREX2; SPRR2B;
SPRR2D; SULT2B1
Keratinization; EDC;
cornified envelope
GLIS1 IL-17Aþ TNF (10 ng for
24 hours);
IL-17Aþ TNF (1 ng for
24 hours);
TNF (1 ng for 24 hours)
IL-13 (20ng for 24 hours)
Abbreviations: EDC, epidermal differentiation complex; IRF3, interferon regulatory factor 3; TNF, tumor necrosis factor; UTR, untranslated region.
For the cytokine-induced experiments, the dosage (ng ml–1) and treatment time are included in brackets.
aOnly the top three most significant results are shown.
bHub genes were defined as the genes having the highest similarity in the module, as assessed by the strength of correlation and the degree of shared neighbors
based on the gene expression data, with other genes in the same module.
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2011; Tsoi et al., 2012). Modules N15 and P26 are signi-
ficantly enriched (Po1104) with genes whose expression
was altered by the knockdown of KLF4 and/or ZNF50
(Zarnegar et al., 2012; Figure 3). We also found that modules
N15 and P23 were significantly (Po1104) enriched with
genes whose expression was altered by deficiency of the long
noncoding RNA TINCR or the STAU1 gene that is regulated
by TINCR. Both of these genes are specifically involved in
regulating the terminal phases of epidermal differentiation
(Kretz et al., 2012). The mapping of these transcription factors
and their target genes to epidermal coexpression modules
demonstrates that WGCNA is capable of detecting, in vivo,
the activity of a p63-initiated and progressively focused
transcription factor network that is engaged in the control of
epidermal differentiation.
With regard to the hair follicle, the two modules most
significantly enriched for function (‘‘keratin filament’’,
Supplementary Table S6 online), N14 and P18, were strongly
overlapping and contained many hair keratins (Schweizer
et al., 2007) and keratin-associated proteins that are
specifically expressed in the hair follicle (Rogers et al.,
2006). Both clusters also contain LHX2, which encodes a
hair follicle stem cell master transcription factor (Mardaryev
et al., 2011), and module N14 contains MSX2, another such
factor. Both of these transcription factors, and most of the
genes encoding hair keratins and keratin-associated proteins,
have also been identified as part of a hair follicle gene
coexpression network in mouse skin (Quigley and Balmain,
2009; Quigley et al., 2011). This conclusion is further
reinforced by the pronounced downregulation of many of
the genes mapping to these modules in bald scalp (Garza
et al., 2012).
With regard to the sebaceous gland, module N17 was
significantly enriched for signature genes expressed by adipose
tissue (Plaisier et al., 2009; Figure 2). We suspect that module
N17 is reflective of sebaceous glands because all visible
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subcutaneous fat was trimmed from our biopsies before
analysis, and because this module was significantly enriched
for PPAR-regulated genes (Supplementary Table S6 online).
PPAR-g stimulates sebocyte lipid production (Trivedi et al.,
2006) and protects sebocytes from apoptosis (Schuster et al.,
2011). Intimate anatomic and molecular relationships exist
between the hair follicle, the sebaceous gland, and the
arrector pili muscle (Lever and Schaumburg-Lever, 1990;
Fujiwara et al., 2011), and a clear connection has been
observed between muscle and hair follicle–related gene
coexpression networks in mouse skin (Quigley et al., 2009).
Consistent with these observations, we found that module
N16 was significantly enriched for genes involved in muscle
contraction (Supplementary Table S6 online).
Tissue architecture as a determinant of gene coexpression
Unlike cell cultures, tissue biopsies consist of multiple
substructures comprising various cell types, which may differ
considerably in normal versus pathological states (Swindell
et al., 2012, 2013). Upon annotation of the modules identified
by WGCNA, we noticed that many of the downregulated
modules were enriched for processes involving the
extracellular matrix, which in skin is mainly found in the
dermis. Noting that a much greater fraction of the cellular
mass of a psoriatic biopsy is epidermal in origin than in a
normal skin biopsy (Supplementary Figure S7e online), we
reasoned that a larger fraction of the RNA in a psoriatic biopsy
would be epidermal, and hence the dermal fraction would be
lower. To test this, we identified two sets of genes from a data
set obtained through laser-capture microdissection of epider-
mal versus appendage-free dermal tissue from normal versus
uninvolved psoriatic skin (Mitsui et al., 2012). These gene sets
shared two properties, including (a) similar expression in laser-
capture microdissection–dissected lesions and uninvolved
skin, and (b) a trend toward dermis- or epidermis-specific
expression. By querying our RNA-seq data set with the
resulting two gene lists, we found an approximately 50%
reduction in dermis-specific transcripts (Supplementary Figure
S7 online). These results suggest that FC estimates for dermis-
derived transcripts are driven downward by epidermal expan-
sion in psoriasis lesions. This process is independent of
intracellular shifts in gene transcription, but may nonetheless
be a key factor influencing gene expression in full-thickness
skin biopsies. Such changes would be predicted to involve not
only dermis-derived mRNAs but also those from other cell
types, including hair follicles, sweat glands, and immune/
inflammatory cells, and indeed this is what we observe for hair
follicle–derived clusters N14 and P18 (Supplementary Table
S7 online). Our findings thus have general implications for
transcriptome studies of inflammatory skin disease, or any
context involving tissue samples that feature a complex
mixture of minority and majority cell types.
In summary, these results bring unprecedented depth and
resolution to the psoriatic transcriptome. They also illuminate
an intricate gene coexpression network driven not only by
inflammatory cells and transcription factors but also by
disease-related differences in tissue architecture. Applied in
tandem with histologically targeted approaches such as
microdissection-coupled transcript profiling, more detailed
examination of coordinate gene expression offers great pro-
mise for an integrated understanding of the genetics, immuno-
logy, and cell biology of psoriasis in the coming years.
MATERIALS AND METHODS
All subjects involved in this study provided written informed consent
under a protocol adherent to the Helsinki Guidelines and approved
by the Institutional Review Board of the University of Michigan
Medical School. Libraries for RNA-seq were generated from poly-
adenylated skin punch biopsy RNA and sequenced at one library per
lane on the Illumina Genome Analyzer IIx. Reads were aligned to the
reference genome NCBI build 37 using TopHat (Garber et al., 2011),
and expression was normalized to the number of reads per kilobase
per million mapped reads. We used the Wilcoxon rank-sum test
to identify DEGs. DEGs were detected based Po10 6 (corresponding
to family-wise error rate o0.025) with a FC 42. Functional
annotation was performed using Gene Ontology (Ashburner et al.,
2000), KEGG (Kanehisa et al., 2012), and Reactome (Matthews
et al., 2009). Transcription factor analyses were performed using
the Ingenuity Pathway Analysis software (www.ingenuity.com).
Significance thresholds were determined by Bonferroni correction.
Coordinate gene expression analysis was performed using the
WGCNA package (Horvath and Dong, 2008), with normal and
lesional psoriatic skin samples being analyzed separately. Gene
expression signatures were identified as described (Swindell et al.,
2012, 2013). Additional details are provided in the Supplementary
Information online. The data discussed in this publication have
been deposited in NCBI’s Gene Expression Omnibus and are
accessible through GEO Series accession number GSE54456
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54456).
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